Drug Profile
Research programme: Bcl-2/Bcl-xl/Mcl-1 inhibitors - Evotec SE
Alternative Names: Mcl-1 inhibitors - Evotec SELatest Information Update: 26 Sep 2019
Price :
$50
*
At a glance
- Originator Evotec AG
- Class
- Mechanism of Action Apoptosis stimulants; Proto-oncogene protein c-bcl-2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 13 Jun 2007 Preclinical trials in Cancer in Germany (unspecified route)